thymidilate synthase poly-epitope peptide vaccine (University of Siena)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namethymidilate synthase poly-epitope peptide vaccine (University of Siena)

Drug Alias NameTSPP vaccine (University of Siena)

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsColonic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Siena

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Siena

Active IndicationsN/A

Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A